Transcatheter Embolization and Occlusion Devices

Sales of cerebral aneurysm/AVM embolization devices totaled just over $1bn in 2018, with sales expected to climb at a CAGR of 4.1% through 2023. Advances in imaging screening techniques have led to increased intervention rates for these disorders, particularly in developed countries. Embolic coils accounted for nearly three quarters of sales in this market; however, flow diverters are expected to experience the most growth over the forecast period. In the peripheral vascular embolization devices market, sales also totaled just over $1bn in 2018, and are expected to increase at a CAGR of 5.1% over the forecast period, with growth largely attributed to increased use of radiolabelled and drug-eluting beads, and the increasing penetration rate of detachable embolization coils. 

This analysis includes a discussion of products, current/forecast markets, and competitors in the global markets for cerebral aneurysm/AVM embolization systems (eg embolic coils, liquid embolics, neuroendovascular stents, and flow diversion systems) and peripheral embolization systems (eg peripheral coils, vascular plugs, liquid embolics, and particles/microspheres). This report provides forecasts for the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the rest of world markets for 2018–23.